These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18767046)

  • 1. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark.
    Lynge E; Poll P
    Am J Epidemiol; 1986 Sep; 124(3):345-52. PubMed ID: 3740035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
    Lynge E; Poll P
    IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
    Adam Y; McIntyre JA; De Bruyn G
    S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
    Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
    Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
    Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Pap smear follow-up in a high-risk population.
    Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.